Multimodality imaging with SPECTRALIS® is helping drive the development of novel therapeutics and changing the course of patient management in eye care. Using an upgradeable platform approach, SPECTRALIS has enhanced the role of spectraldomain OCT by integrating it with confocal scanning laser ophthalmoscopy (cSLO). The combination of these two technologies has enabled new imaging capabilities, such as TruTrack™ Active Eye Tracking, and BluePeak™ blue laser autofluorescence, providing clinicians with unique views of the structure and function of the eye. Enhanced anatomical details, 1 micron measurable change1 and automatic rescan at followup are the direct benefits of TruTrack active eye tracking and simultaneous dualbeam imaging. These two technologies are at the core of the SPECTRALIS product platform. Enhanced image detail comes from Heidelberg Noise Reduction™, which improves images like Dolby® noise reduction improves recorded sound. Measuring change with 1 micron reproducibility is possible with AutoRescan™, which automatically places followup scans in precisely the same location, bypassing operator variability. This precision is the product of 20 years of proven HRT technology, which paved the way for the dualbeam approach to imaging. The SPECTRALIS platform includes multiple models at various price points. The workhorse model in the family is the SPECTRALIS OCT, an economical, easytouse version with onetouch preset scan patterns and AutoRescan. Additional models built upon this base platform allow clinicians to tailor a system to the current needs of the practice. As the practice grows, upgrade options allow the SPECTRALIS system to grow along with it.